4 Stories in coverage 5 Programs 103 recruiting Registered trials 8-K Sep 14 Latest SEC filing, period to Sep 12 Aug 25 Latest story
Timeline 4 Pipeline 5 Trials 10
All4 Regulatory1 Trials and readouts2 Filings and people1
Pipeline by stage
Phase 3 1 Phase 2 1 Phase 1 3
Details
Headquarters San Diego, CA Incorporated Delaware Industry Biological Products, (No Diagnostic Substances) Formerly NantKwest, Inc. (to 2021); Conkwest, Inc. (to 2015); ZelleRx Corp (to 2009) Also known as Conkwest, Inc., IBRX, NantKwest, Inc., ZelleRx Corp How the company describes itself ImmunityBio develops immunotherapies including an IL-15 superagonist, adenovirus-vectored vaccines, and allogeneic and autologous NK-cell therapies for cancer and infectious diseases. The company's Cancer BioShield platform targets natural killer cells, cytotoxic T cells, and memory T cells. source
